IBDEI1K5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27653,1,5,0)
 ;;=5^Disorder of Soft Tissue, Unsp
 ;;^UTILITY(U,$J,358.3,27653,2)
 ;;=^336762
 ;;^UTILITY(U,$J,358.3,27654,0)
 ;;=729.99^^162^1785^25
 ;;^UTILITY(U,$J,358.3,27654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27654,1,4,0)
 ;;=4^729.99
 ;;^UTILITY(U,$J,358.3,27654,1,5,0)
 ;;=5^Disorder of Soft Tissue, Other
 ;;^UTILITY(U,$J,358.3,27654,2)
 ;;=^336656
 ;;^UTILITY(U,$J,358.3,27655,0)
 ;;=729.92^^162^1785^38
 ;;^UTILITY(U,$J,358.3,27655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27655,1,4,0)
 ;;=4^729.92
 ;;^UTILITY(U,$J,358.3,27655,1,5,0)
 ;;=5^Non-Traumatic Hematoma Soft Tiss
 ;;^UTILITY(U,$J,358.3,27655,2)
 ;;=^336655
 ;;^UTILITY(U,$J,358.3,27656,0)
 ;;=729.91^^162^1785^59
 ;;^UTILITY(U,$J,358.3,27656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27656,1,4,0)
 ;;=4^729.91
 ;;^UTILITY(U,$J,358.3,27656,1,5,0)
 ;;=5^Post-traumatic Seroma
 ;;^UTILITY(U,$J,358.3,27656,2)
 ;;=^336654
 ;;^UTILITY(U,$J,358.3,27657,0)
 ;;=274.00^^162^1785^31
 ;;^UTILITY(U,$J,358.3,27657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27657,1,4,0)
 ;;=4^274.00
 ;;^UTILITY(U,$J,358.3,27657,1,5,0)
 ;;=5^Gouty Arthritis NOS
 ;;^UTILITY(U,$J,358.3,27657,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,27658,0)
 ;;=274.01^^162^1785^34
 ;;^UTILITY(U,$J,358.3,27658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27658,1,4,0)
 ;;=4^274.01
 ;;^UTILITY(U,$J,358.3,27658,1,5,0)
 ;;=5^Gouty Arthropathy, Acute
 ;;^UTILITY(U,$J,358.3,27658,2)
 ;;=^338226
 ;;^UTILITY(U,$J,358.3,27659,0)
 ;;=274.02^^162^1785^33
 ;;^UTILITY(U,$J,358.3,27659,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27659,1,4,0)
 ;;=4^274.02
 ;;^UTILITY(U,$J,358.3,27659,1,5,0)
 ;;=5^Gouty Arthritis w/o Tophi, CHR
 ;;^UTILITY(U,$J,358.3,27659,2)
 ;;=^338227
 ;;^UTILITY(U,$J,358.3,27660,0)
 ;;=274.03^^162^1785^32
 ;;^UTILITY(U,$J,358.3,27660,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27660,1,4,0)
 ;;=4^274.03
 ;;^UTILITY(U,$J,358.3,27660,1,5,0)
 ;;=5^Gouty Arthritis w/ Tophi, CHR
 ;;^UTILITY(U,$J,358.3,27660,2)
 ;;=^338228
 ;;^UTILITY(U,$J,358.3,27661,0)
 ;;=781.0^^162^1786^71
 ;;^UTILITY(U,$J,358.3,27661,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27661,1,4,0)
 ;;=4^781.0
 ;;^UTILITY(U,$J,358.3,27661,1,5,0)
 ;;=5^Tremor
 ;;^UTILITY(U,$J,358.3,27661,2)
 ;;=^23827
 ;;^UTILITY(U,$J,358.3,27662,0)
 ;;=351.0^^162^1786^1
 ;;^UTILITY(U,$J,358.3,27662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27662,1,4,0)
 ;;=4^351.0
 ;;^UTILITY(U,$J,358.3,27662,1,5,0)
 ;;=5^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,27662,2)
 ;;=Bell's Palsy^13238
 ;;^UTILITY(U,$J,358.3,27663,0)
 ;;=386.11^^162^1786^74
 ;;^UTILITY(U,$J,358.3,27663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27663,1,4,0)
 ;;=4^386.11
 ;;^UTILITY(U,$J,358.3,27663,1,5,0)
 ;;=5^Vertigo, Benign Positional
 ;;^UTILITY(U,$J,358.3,27663,2)
 ;;=^269480
 ;;^UTILITY(U,$J,358.3,27664,0)
 ;;=784.0^^162^1786^23
 ;;^UTILITY(U,$J,358.3,27664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27664,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,27664,1,5,0)
 ;;=5^Headache
 ;;^UTILITY(U,$J,358.3,27664,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,27665,0)
 ;;=346.20^^162^1786^13
 ;;^UTILITY(U,$J,358.3,27665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27665,1,4,0)
 ;;=4^346.20
 ;;^UTILITY(U,$J,358.3,27665,1,5,0)
 ;;=5^Cluster/Migraine Variant
 ;;^UTILITY(U,$J,358.3,27665,2)
 ;;=^294062
 ;;^UTILITY(U,$J,358.3,27666,0)
 ;;=346.21^^162^1786^14
 ;;^UTILITY(U,$J,358.3,27666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27666,1,4,0)
 ;;=4^346.21
 ;;^UTILITY(U,$J,358.3,27666,1,5,0)
 ;;=5^Cluster/Migraine Variant, Resistant To Meds
 ;;^UTILITY(U,$J,358.3,27666,2)
 ;;=^293879
 ;;
 ;;$END ROU IBDEI1K5
